<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05098158</url>
  </required_header>
  <id_info>
    <org_study_id>18111</org_study_id>
    <nct_id>NCT05098158</nct_id>
  </id_info>
  <brief_title>Community-Engaged Options to Facilitate Opioid Reduction</brief_title>
  <acronym>COMFORT</acronym>
  <official_title>Community-Engaged Options to Maximize and Facilitate Opioid Reduction Through Treatment</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Washington State University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Spokane Regional Health District</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Washington Institute for Translational Health Science (KL2)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Rayce Rudeen Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Washington State University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study investigates how adults prescribed opioids for chronic noncancer pain respond to&#xD;
      invitations to try non-opioid options of massage therapy, yoga therapy, chiropractic and&#xD;
      physical therapies. Due to the COVID-19 pandemic, these options will be available via&#xD;
      telehealth consultation visits using a computer or smartphone with internet connection. The&#xD;
      investigators will measure effects on pain, pain-related symptoms, and opioid use over time&#xD;
      using a single-group design.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Participants will be recruited from local primary care practices and asked to complete a&#xD;
      baseline survey. They will then meet with a registered nurse via teleconference for a&#xD;
      complete pain assessment. At the end of the session, participants will be asked to choose two&#xD;
      of four available modalities for telehealth consultation. Participants will be scheduled for&#xD;
      six telehealth sessions, once per week x six weeks with three consultations per each chosen&#xD;
      therapy. Measurements of pain, mood, sleep, medicine use will be captured at baseline, three&#xD;
      weeks and six weeks and examined for changes over time.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 10, 2020</start_date>
  <completion_date type="Anticipated">December 15, 2021</completion_date>
  <primary_completion_date type="Anticipated">October 30, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>Single group studied over 6 weeks time</intervention_model_description>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Patient-Reported Outcomes Measurement Information System (PROMIS) Pain intensity rating</measure>
    <time_frame>6 weeks</time_frame>
    <description>3 items asking about pain severity (range 3 to 15 with higher score worse pain intensity)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>PROMIS Pain interference rating</measure>
    <time_frame>6 weeks</time_frame>
    <description>8 items asking about pain interference with life (range 8 to 40 with higher score worse pain interference)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Depressive symptoms using Patient Health Questionnaire (PHQ-8)</measure>
    <time_frame>6 weeks</time_frame>
    <description>Patient Health Questionnaire (PHQ-8) 8-item scale with score range 0-24 (higher score is worsened depressive symptoms)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>PROMIS Self-efficacy for managing symptoms short form 4a</measure>
    <time_frame>6 weeks</time_frame>
    <description>Self-efficacy self-report (range 4-20 with higher score better symptom management self-efficacy)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>PROMIS Self-efficacy for managing emotions short form 4a</measure>
    <time_frame>6 weeks</time_frame>
    <description>Self-efficacy self-report (range 4-20 with higher score better emotion management self-efficacy)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Anxiety using Generalized Anxiety Disorder (GAD-7)</measure>
    <time_frame>6 weeks</time_frame>
    <description>7-item scale with score range 0-21 (higher score is worsened anxiety)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Interpersonal Needs Questionnaire</measure>
    <time_frame>6 weeks</time_frame>
    <description>9-item scale asking how one feels about others score range 0-18 (lower score indicates more unmet interpersonal needs)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Current Opioid Misuse Measure</measure>
    <time_frame>6 weeks</time_frame>
    <description>17-item scale to ask about use of opioids (range 0-64 with higher scores indicating more misuse)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Spiritual Well-being Index</measure>
    <time_frame>6 weeks</time_frame>
    <description>4-items to ask about spiritual well-being (range 4-20 with higher scores indicating more spiritual well-being)</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Attendance in scheduled telehealth sessions</measure>
    <time_frame>6 weeks</time_frame>
    <description>Percentage of attendance for each participant in their scheduled telehealth sessions (e.g. 3/6 sessions = 50%)</description>
  </other_outcome>
  <other_outcome>
    <measure>Satisfaction with intervention</measure>
    <time_frame>6 weeks</time_frame>
    <description>3-item program satisfaction survey to gauge participant satisfaction with the interventions using 1-7 Likert scale (score range 3 to 21 where higher score indicates higher satisfaction)</description>
  </other_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Chronic Pain</condition>
  <arm_group>
    <arm_group_label>Single arm pain treatment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Arm includes usual pain care plus the chosen two telehealth interventions x 6 weeks</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Non-pharmacological pain treatment</intervention_name>
    <description>Participant selects from telehealth consultation on massage therapy, yoga therapy, chiropractic and physical therapies.</description>
    <arm_group_label>Single arm pain treatment</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  enrollment in treatment at the CHAS Perry St or partnering clinic;&#xD;
&#xD;
          -  age greater than 18 years;&#xD;
&#xD;
          -  ability to read, speak, and write English;&#xD;
&#xD;
          -  diagnosed with a chronic, non-cancer-based painful medical condition;&#xD;
&#xD;
          -  ability to provide informed consent.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  pregnancy;&#xD;
&#xD;
          -  diagnosis of a cancer-based painful medical condition;&#xD;
&#xD;
          -  any other medical or psychiatric condition that the PI or Co-PI physician of record&#xD;
             determine might compromise safe study participation (including but not limited to&#xD;
             active psychosis, history of frequent psychiatric hospitalizations, severe anxiety&#xD;
             with claustrophobia, aggression)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Marian Wilson, PhD</last_name>
    <phone>5093247443</phone>
    <email>marian.wilson@wsu.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Community Health Association of Spokane</name>
      <address>
        <city>Spokane</city>
        <state>Washington</state>
        <zip>99201</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tori Dezellem</last_name>
      <phone>509-444-8888</phone>
      <email>tdezellem@chas.org</email>
    </contact>
    <contact_backup>
      <last_name>Kaleena Reynolds</last_name>
      <phone>509-444-8888</phone>
      <email>kreynolds@chas.org</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Washington State University College of Nursing</name>
      <address>
        <city>Spokane</city>
        <state>Washington</state>
        <zip>99201</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marian Wilson, PhD</last_name>
      <phone>509-324-7443</phone>
      <email>marian.wilson@wsu.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>July 13, 2020</study_first_submitted>
  <study_first_submitted_qc>October 15, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">October 28, 2021</study_first_posted>
  <last_update_submitted>October 15, 2021</last_update_submitted>
  <last_update_submitted_qc>October 15, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 28, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>chronic pain</keyword>
  <keyword>opioid</keyword>
  <keyword>complementary</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Chronic Pain</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

